ReAct Asia Pacific.
J Infect Public Health. 2023 Dec;16 Suppl 1:125-128. doi: 10.1016/j.jiph.2023.10.043. Epub 2023 Nov 2.
Antibiotic resistance (ABR) is a global health threat with the potential to cause mortality and morbidity on an unprecedented scale. In the past, civil society organizations (CSOs) have been successful in complementing the efforts of government health systems, thereby shaping the course of various public health programs, especially in low- and middle-income countries (LMICs). This article reports the outcomes of a CSO sensitization workshop held by one of the regional nodes of ReAct and highlights the perspectives of CSOs on their role in supporting the implementation of national and sub-national action plans for AMR mitigation. CSOs can contribute to (i) redefining the AMR narrative, (ii) generating the data for action and policy change, (iii) advocating for policy change, (iv) promoting research and influencing decisions pertaining to research in AMR, and (v) undertaking behavioral change communication for different target groups, among others. Governments in LMICs could leverage the expertise of CSOs by playing the role of facilitator while ensuring that the interventions align with national priorities and are sustainable. Efforts to ensure diverse funding and capacity building among CSOs should happen in parallel to ensure maximum impact on communities.
抗生素耐药性(ABR)是一个全球性的健康威胁,有可能以前所未有的规模造成死亡和发病。过去,民间社会组织(CSO)在补充政府卫生系统的工作方面取得了成功,从而塑造了各种公共卫生计划的进程,特别是在中低收入国家(LMIC)。本文报告了 ReAct 区域节点之一举办的 CSO 宣传研讨会的结果,并强调了 CSO 对其在支持国家和国家以下一级抗菌素耐药性缓解行动计划实施方面的作用的看法。CSO 可以为以下方面做出贡献:(i)重新定义 AMR 叙述;(ii)为行动和政策变革生成数据;(iii)倡导政策变革;(iv)促进与 AMR 研究相关的研究并影响决策;(v)针对不同目标群体开展行为改变传播等。中低收入国家的政府可以通过发挥促进者的作用来利用 CSO 的专业知识,同时确保干预措施符合国家优先事项并具有可持续性。应同时努力确保 CSO 之间的资金来源多样化和能力建设,以确保对社区产生最大影响。